Search
You have searched for "regulatory"
Showing 1-10 of 10000
Proxy adviser ISS backs shareholder proposal for Toshiba investigation
TOKYO (Reuters) - Toshiba Corp shareholders should vote in favour of a proposed independent investigation into allegations that investors were pressured ahead of last year's annual general meeting, an influential proxy adviser has recommended.
Covid-19: No reason to have misgivings about vaccines
KUALA LUMPUR (Bernama): Having grappled with the Covid-19 pandemic for a year now, vaccines that promise to curb the transmission of the deadly coronavirus are finally available in Malaysia.
Covid-19: First batch of AstraZeneca vaccine expected to arrive in second quarter
KUALA LUMPUR (Bernama): The first batch of AstraZeneca Covid-19 vaccine to Malaysia is expected to arrive in the second quarter of this year.
RHB maintains 'buy' on Pos Malaysia
KUALA LUMPUR: RHB Research has kept its earnings estimates on Pos Malaysia Bhd on optimism over the postal operator's turnaround prospects and leading position in the parcel delivery market.
GLOBAL MARKETS: Stocks edge down as investors hit pause, watch bond yields
NEW YORK: Global equity markets were little changed on Tuesday as Wall Street retreated and investors took stock of gains from Monday's surge, pausing to gauge whether a bond yield jump had run its course.
UK to receive 10 million AstraZeneca COVID-19 vaccine doses from India's Serum Institute
(Reuters) - The UK will receive 10 million AstraZeneca COVID-19 vaccine doses made by the Serum Institute of India (SII), the UK government said in a statement on Tuesday.
Ant tells staff it will find solution for unsellable shares
NEW YORK: Ant Group Co told employees it would eventually go public and promised to help those who need to monetise their shares sooner, seeking to boost morale four months after Chinese regulators torpedoed the fintech giant’s blockbuster listing.
DG: Two more vaccines get conditional approval
PUTRAJAYA: China’s Sinovac and the UK’s AstraZeneca Covid-19 vaccines have received conditional approval from Malaysia.
Govt still in talks with Johnson & Johnson
PETALING JAYA: The Johnson & Johnson’s single dose vaccine may be too little and too late for MalayÂsia, and this is a concern currently being addressed by the government with the manufacturer, says Khairy Jamaluddin.
Private hospitals want vaccines too
GEORGE TOWN: Private hospitals in Penang have been flooded with calls from people who want to be vaccinated now instead of waiting for their turn under the three-phase national vaccination plan.
